RFG
ELV icon

REAP Financial Group’s Elevance Health ELV Stock Holding History

REAP Financial Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1
Closed -$184 – 588
2024
Q4 		$184 Buy
+1
New +$418 ﹤0.01% 567

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

REAP Financial Group's ELV Position: Q1 2025 in Review

REAP Financial Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 1 share — an estimated $184 sold.

REAP Financial Group first reported a position in ELV in Q4 2024 and held it in 1 quarter. The position peaked at $184 in Q4 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • REAP Financial Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • REAP Financial Group sold 1 Elevance Health share in Q1 2025, an estimated $184.
  • REAP Financial Group first reported a position in Elevance Health in Q4 2024 and held it in 1 quarter.
  • REAP Financial Group's Elevance Health position peaked at $184 in Q4 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on REAP Financial Group's 13F filing for Q1 2025, filed 14 May 2025.